191 related articles for article (PubMed ID: 16026227)
1. Escitalopram in the treatment of generalized anxiety disorder.
Baldwin DS; Nair RV
Expert Rev Neurother; 2005 Jul; 5(4):443-9. PubMed ID: 16026227
[TBL] [Abstract][Full Text] [Related]
2. Escitalopram therapy for major depression and anxiety disorders.
Baldwin DS; Reines EH; Guiton C; Weiller E
Ann Pharmacother; 2007 Oct; 41(10):1583-92. PubMed ID: 17848424
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder.
Baldwin D; Buis C; Mayers A
Expert Rev Neurother; 2002 Sep; 2(5):717-24. PubMed ID: 19810988
[TBL] [Abstract][Full Text] [Related]
4. Escitalopram in the treatment of anxiety symptoms associated with depression.
Bandelow B; Andersen HF; Dolberg OT
Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
[TBL] [Abstract][Full Text] [Related]
5. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
Demyttenaere K; Andersen HF; Reines EH
Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram for the treatment of major depression and anxiety disorders.
Höschl C; Svestka J
Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
Olié JP; Tonnoir B; Ménard F; Galinowski A
Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
[TBL] [Abstract][Full Text] [Related]
8. How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database.
Baldwin DS; Stein DJ; Dolberg OT; Bandelow B
Hum Psychopharmacol; 2009 Jun; 24(4):269-75. PubMed ID: 19334042
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions.
Stein DJ; Kasper S; Andersen EW; Nil R; Lader M
Depress Anxiety; 2004; 20(4):175-81. PubMed ID: 15643634
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
12. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
Bose A; Korotzer A; Gommoll C; Li D
Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
[TBL] [Abstract][Full Text] [Related]
13. Citalopram and suicidality in adult major depression and anxiety disorders.
Pedersen AG
Nord J Psychiatry; 2006; 60(5):392-9. PubMed ID: 17038305
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of generalized anxiety disorder.
Davidson JR
J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
[TBL] [Abstract][Full Text] [Related]
15. Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensions.
Stein DJ; Andersen EW; Lader M
Eur Neuropsychopharmacol; 2006 Jan; 16(1):33-8. PubMed ID: 16014329
[TBL] [Abstract][Full Text] [Related]
16. Suicide rates in short-term randomized controlled trials of newer antidepressants.
Hammad TA; Laughren TP; Racoosin JA
J Clin Psychopharmacol; 2006 Apr; 26(2):203-7. PubMed ID: 16633153
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
Boulenger JP; Huusom AK; Florea I; Baekdal T; Sarchiapone M
Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
Wagner KD
Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
[TBL] [Abstract][Full Text] [Related]
19. [Severe forms of depression: the efficacy of escitalopram].
Spadone C
Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
Fantino B; Moore N; Verdoux H; Auray JP
Int Clin Psychopharmacol; 2007 Mar; 22(2):107-15. PubMed ID: 17293711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
